2 Controversial Stocks With High Returns — Are They Worth the Risk?

Valeant and CGI Group offer big returns, but there are reasons to be concerned.

These two companies seem to have a lot in common. Both have richly rewarded their shareholders in recent years, but not without controversy. Specifically, observers have called into question their accounting practices, and a lot of smart people are betting that their share prices will fall. At the same time, many other smart people believe these companies will continue to soar. If the past is any indication, this second group of people will be right.

1. Valeant Pharmaceuticals

If you bought shares in Valeant Pharmaceuticals (TSX: VRX)(NYSE: VRX) five years ago and held on, then congratulations. Over this time, the company’s shares have returned 60% per year.

The key to Valeant’s success has been its emphasis on acquisitions, led by CEO Michael Pearson. By simply buying drug portfolios and drug companies, Valeant saves itself from having to incur steep research and development costs. Once an acquisition is made, Valeant has proved itself very adept at wringing costs out of its acquired business.

But this strategy has created some controversy, specifically surrounding Valeant’s accounting practices. First of all, the company is able to showcase inflated margins because its acquisitions save it from normal business expenses like R&D. Secondly, Valeant reports numerous accounting measures, like adjusted operating cash flow and cash earnings per share, that don’t include accounting-related costs. As an investor, it can be difficult to gauge just how profitable the company really is.

The stock is also quite expensive by almost any standard, trading at over six times revenue. It’s not easy to tell whether Valeant justifies such a stock price, but it is easy to realize that this stock is a gamble.

2. CGI Group

Although CGI Group’s (TSX: GIB.A)(NYSE: GIB) shares haven’t performed as well as Valeant’s, they’re still nothing to sneeze at. Over the past five years, CGI’s shares have returned 29% per year, but also like Valeant, this has not come without controversy.

The problem once again concerns accounting, specifically related to acquisitions. It’s a common trick for acquirers to write down an asset right before buying it — the asset can then be written up again once it’s owned, helping to boost revenue and earnings. CGI is accused of abusing this practice, especially with its gigantic purchase of Logica in 2012.

So while it may be tempting to buy either of these companies, both of them are a gamble that’s probably not worth taking.

Fool contributor Benjamin Sinclair holds no positions in any of the stocks mentioned in this article. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

oil pumps at sunset
Energy Stocks

How a $25,000 TFSA Could Fund Your Retirement

Canadians can turn to the TFSA to help provide a meaningful income stream in retirement.

Read more »

Canada day banner background design of flag
Investing

3 of the Best Canadian Stocks to Buy Right Now

These three Canadian stocks are ideal for balancing wealth-creation opportunities with stability and income generation in this uncertain outlook.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

TFSA Strategy: How to Earn $500 a Month in Tax-Free Dividend Income

Canadians can earn $500 in tax-free dividend income or another desired amount every month using a simple TFSA strategy.

Read more »

coins jump into piggy bank
Energy Stocks

Canadian Natural Resources vs. Enbridge: The Better Dividend Stock to Buy Today

Both CNQ and ENB have impressive payout records, consistently paying and increasing their dividends for decades.

Read more »

doctor uses telehealth
Dividend Stocks

TFSA Investors: This Monthly Dividend Stock Yields 7.6%

This REIT offers investors a monthly yield investors and a regular and frequent passive income stream to supplement their regular…

Read more »

shopper chooses vegetables at grocery store
Dividend Stocks

Loblaw vs. Empire: Which Grocery Stock Would I Choose for Long-Term Growth?

Both grocers benefit from repeat shoppers. I’d give Loblaw the edge for the ways it can earn more from those…

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

2 Canadian Stocks to Buy and Hold for 20 More Years

CP Rail (TSX:CP) and another outstanding Canadian stock that's more than worth holding for many decades.

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

2 Top TSX ETFs to Buy and Hold in a TFSA Forever

Looking for top TSX ETFs for your TFSA? Explore how VFV and VDY combine U.S. stock exposure and Canadian dividends…

Read more »